Pig breeding and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease duplex inactivated vaccine and preparation method and application thereof
A technology of NVDC-JXA1, double inactivated vaccine, applied in antiviral agents, viral antigen components, pharmaceutical formulations, etc., can solve problems such as the misery of pig farm operators, the mutual interference of vaccines and vaccines, and the inability to meet immunization needs. , to achieve the effect of being easy to popularize and apply, the preparation method is simple and easy to operate, and the immune density and the cost of vaccines are reduced
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0034] A preparation method of porcine reproductive and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease dual inactivated vaccine, which comprises the following steps:
[0035]1) Preparation of porcine reproductive and respiratory syndrome virus liquid: inoculate Marc-145 cells that have grown into a single layer with 5% volume ratio of porcine reproductive and respiratory syndrome virus NVDC-JXA1 strain, rotate culture, when 70% When the above cells have cytopathic changes, harvest the porcine reproductive and respiratory syndrome virus-infected cell culture medium, freeze and thaw, remove cell debris by centrifugation or filtration, then inactivate with formaldehyde solution, and then concentrate and concentrate to the original volume by ultrafiltration half of the concentrated porcine reproductive and respiratory syndrome virus liquid;
[0036] 2) Preparation of porcine parvovirus liquid: using the method of synchronous inoculation, while the ST cells are su...
Embodiment 1
[0042] A preparation of porcine reproductive and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease dual inactivated vaccine is carried out according to the following steps: 1) the volume ratio of porcine reproductive and respiratory syndrome virus NVDC-JXA1 strain is 5% Inoculate the Marc-145 cells that have grown into a single layer, and rotate them at 37°C at a speed of 8 rpm. When more than 70% of the cells show cytopathic changes, harvest the culture medium of porcine reproductive and respiratory syndrome virus-infected cells, freeze-thaw Twice, remove cell debris by centrifugation or filtration, then inactivate with formaldehyde solution with a final concentration of 0.1% at 37°C for 18 hours, and then concentrate by ultrafiltration to half of the original volume to obtain concentrated porcine reproductive and respiratory syndrome virus liquid ; 2) Using the method of synchronous inoculation, when the ST cells are subcultured in separate bottles, the porcine...
Embodiment 2
[0044] A preparation of porcine reproductive and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease dual inactivated vaccine is carried out according to the following steps: 1) the volume ratio of porcine reproductive and respiratory syndrome virus NVDC-JXA1 strain is 5% Inoculate the Marc-145 cells that have grown into a monolayer, and rotate at 37°C at a speed of 9 rpm. When more than 70% of the cells show cytopathic changes, harvest the culture medium of porcine reproductive and respiratory syndrome virus-infected cells, freeze-thaw Twice, remove cell debris by centrifugation or filtration, then inactivate with formaldehyde solution with a final concentration of 0.1% at 37°C for 18 hours, and then concentrate by ultrafiltration to half of the original volume to obtain concentrated porcine reproductive and respiratory syndrome virus liquid ; 2) Using the method of synchronous inoculation, when the ST cells are subcultured in separate bottles, the porcine parvovi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com